iTRAQ-based proteomic analysis after mesenchymal stem cell line transplantation for ischemic stroke

Area of Science:

• Neuroscience
• Regenerative Medicine
• Proteomics

Background:

• Mesenchymal stem cells (MSCs) show therapeutic potential for ischemic stroke recovery in animal models.
• The precise molecular mechanisms driving MSC-mediated functional recovery remain incompletely understood.

Purpose of the Study:

• To comprehensively identify brain protein alterations in rats following MSC transplantation for ischemic stroke.
• To explore the multi-target therapeutic mechanisms of MSCs using a proteomics approach.

Main Methods:

• Utilized isobaric tagging for relative and absolute protein quantification (iTRAQ) to analyze protein expression changes in rat brains post-B10 MSC transplantation.
• Conducted bioinformatic analysis to identify protein functions and pathways.
• Performed immunohistochemical staining for EAAT1 and measured ATP levels to validate proteomic findings.

Main Results:

• Identified 28 differentially expressed proteins, primarily linked to energy metabolism, glutamate excitotoxicity, oxidative stress, and neural plasticity.
• Observed decreased EAAT1 expression in control groups compared to normal levels in the MSC-treated group.
• Found significantly higher ATP levels in the MSC-transplanted group, supporting proteomic data.

Conclusions:

• B10 MSC transplantation may exert therapeutic effects by modulating the acute ischemic cascade through multiple molecular pathways.
• The study provides crucial insights into the multi-target mechanisms of MSCs in treating ischemic stroke.
• Findings highlight potential therapeutic targets for enhancing MSC-based stroke treatments.